实现药品创新的动态效率:确定价值和所需支付的最佳份额
Beth Woods1, James Lomas1,2, Mark Sculpher1
1Centre for Health Economics, University of York, York, UK.
Health economics
|January 16, 2024
概括
制药定价政策应平衡静态和动态效率,以激励创新. 新药的最佳价值共享率约为20%,确保长期的人口健康和社会福利.
科学领域:
- 卫生经济学 卫生经济学
- 制药政策 制药政策
- 创新经济学的创新经济学
背景情况:
- 目前对药品的成本效益分析往往忽视了动态效率和创新激励措施.
- 药品定价政策可能无法充分考虑长期的社会利益和成本.
研究的目的:
- 为制药定价政策设计提供一个框架,以实现动态效率.
- 为制造商确定最佳的奖励水平,以平衡静态和动态的收益和成本.
- 根据对付款的创新反应,确定最大化长期人口健康的价值份额.
主要方法:
- 开发了一个连贯的框架来分析制造商奖励的长期静态和动态收益和成本.
- 利用对付款的创新反应的证据来估计最佳价值份额.
- 重新分析了英国国家卫生和护理卓越研究所 (NICE) 技术评估的样本.
主要成果:
- 据估计,新药价值的最佳份额约为20% (范围:6%-51%),取决于创新的数量和质量对付款的反应.
- 重新分析表明,英国国家卫生服务 (NHS) 支付的价值和价格溢价的比例往往过高.
- 在英国应用最佳股份可以为公众健康和更广泛的社会福利带来实质性的好处.
结论:
- 药品定价政策需要纳入动态效率和创新激励措施.
- 在一些医疗保健系统中,目前的价值共享机制可能会过度补偿制造商.
- 通过各种支付机制实现最佳价值共享,包括卫生技术评估 (HTA) 机构的间接价格监管.
相关概念视频
Drug Discovery: Overview
7.9K
Drug discovery is a multifaceted process involving extensive screening, testing, and optimization of lead compounds to identify potential new drugs for therapeutic use. It combines several approaches, including screening large numbers of natural products, chemical modification of known active molecules, identification of new drug targets, and rational design based on biological mechanisms and drug-receptor structure. These approaches are carried out in both academic research laboratories and...
7.9K
Biopharmaceutics and Pharmacokinetics: Overview
2.0K
Understanding drugs, drug products, and their performance in pharmaceutical science is pivotal. Drugs, whether simple molecules or complex compounds, are designed to interact with the body's biological systems to diagnose, treat, or prevent diseases. Drug products include various delivery systems such as tablets, capsules, injections, and inhalers. The performance of these drug products is gauged by their ability to deliver the active ingredient to the desired site of action at the...
2.0K
Drug Administration and Therapy Phases: Overview
471
Drugs, the chemical agents used in diagnosing, treating, or preventing diseases, undergo a four-phase process of development: pharmaceutic, pharmacokinetics, pharmacodynamics, and therapeutic.
The pharmaceutical phase focuses on leveraging the physicochemical properties of the drug to design and manufacture an effective product. Variants include orally administered tablets or capsules, topical creams or ointments, and parenteral-delivery solutions or emulsions.
The pharmacokinetic phase...
The pharmaceutical phase focuses on leveraging the physicochemical properties of the drug to design and manufacture an effective product. Variants include orally administered tablets or capsules, topical creams or ointments, and parenteral-delivery solutions or emulsions.
The pharmacokinetic phase...
471
Factors Influencing Drug Absorption: Pharmaceutical Parameters
134
Solid dosage forms such as tablets and capsules undergo rigorous manufacturing processes to ensure stability and effectiveness. Their dissolution and absorption properties are influenced significantly by the choice of excipients (inactive ingredients that serve various roles in the formulation), and the methodology applied during production. The manufacturing parameters, such as compression force and granulation techniques, significantly affect dissolution rates. Elevated compression forces...
134
Structure-Activity Relationships and Drug Design
726
Drug design is a dynamic field that involves discovering and developing new medications based on specific biological targets. This process heavily relies on structure-activity relationships (SAR) and quantitative structure-activity relationships (QSAR) to guide the design and optimization of efficient drugs.
SAR studies the intricate relationship between a drug's chemical structure and biological activity. It focuses on understanding how modifications to a drug's structure can influence...
SAR studies the intricate relationship between a drug's chemical structure and biological activity. It focuses on understanding how modifications to a drug's structure can influence...
726
Bioequivalence: Overview
1.0K
Pharmaceutical equivalents, by definition, are drug products with the same active ingredient in the same quantities, encapsulated in identical dosage forms, and intended for the same administration routes. These pharmaceutical equivalents are deemed bioequivalent if the bioavailability of the active entity in the drug preparations is similar. Moreover, pharmaceutical equivalents demonstrating bioequivalence are also regarded as therapeutically equivalent. This means that when used as directed,...
1.0K


